Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	7.59	129.68	120.53
Graham Fair Price	-19.43	1.40	1.74
PEG	-795.19	-10.08	-1.13
Price/Book	-28.54	1.96	2.75
Price/Cash Flow	189.28	-161.20	55.72
Prices/Earnings	76.54	492.90	279.20
Price/Sales	-5.55	9.25	9.79
Price/FCF	189.28	-161.20	55.72
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	4.38	0.25	0.24
Operating Margin	-42.86	0.03	0.04
ROA	-53.81	< 0.005	< 0.005
ROE	< 0.005	< 0.005	-59.52
ROIC	< 0.005	< 0.005	-79.42
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.13	0.11	20.02
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	< 0.005	-0.42	-5042.15
EPS QOQ	2.48	-0.49	-80.28
FCF QOQ	4.36	-1.33	-69.51
Revenue QOQ	< 0.005	0.01	326.24
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	67.39	69.04	2.45
Days Sales Outstanding (DSO)	108.21	105.78	-2.25
Inventory Turnover	1.34	1.30	-2.39
Debt/Capitalization	0.19	0.13	-33.28
Quick Ratio	1.37	2.31	67.82
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	7.39	9.36	26.63
Cash	0.55	2.43	340.51
Capex	-0.15	-0.12	18.61
Free Cash Flow	0.36	-0.11	-68.72
Revenue	2.07	1.99	-4.20
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	2.03	3.02	48.89
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	10.23	-3.12	-69.46
Naive Interpretation	Member

06 - Financial Health · Bad

Rating